{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T00:27:38Z","timestamp":1717633658138},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.hfc.2024.03.002","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T13:24:48Z","timestamp":1712237088000},"page":"295-305","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis"],"prefix":"10.1016","volume":"20","author":[{"given":"Andrea","family":"Barison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignazio Alessio","family":"Gueli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Pizzino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysanthos","family":"Grigoratos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2024.03.002_bib1","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-022-10235-9","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques : A position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology","author":"Merlo","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2024.03.002_bib2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijcard.2021.02.003","article-title":"Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications","volume":"331","author":"Barison","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib3","first-page":"1","article-title":"Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction","author":"Barison","year":"2020","journal-title":"Hear Fail Rev"},{"key":"10.1016\/j.hfc.2024.03.002_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.03.002_bib5","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to image cardiac amyloidosis: a practical approach","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","article-title":"Cardiovascular magnetic resonance for amyloidosis","volume":"20","author":"Fontana","year":"2015","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.hfc.2024.03.002_bib7","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib9","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.amjcard.2008.10.039","article-title":"Comparison of magnetic resonance imaging versus doppler echocardiography for the evaluation of left ventricular diastolic function in patients with cardiac amyloidosis","volume":"103","author":"Rubinshtein","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2459\/JCM.0000000000000188","article-title":"Left atrial function in cardiac amyloidosis","volume":"17","author":"Di Bella","year":"2016","journal-title":"J\u00a0Cardiovasc Med"},{"key":"10.1016\/j.hfc.2024.03.002_bib11","article-title":"Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates","volume":"31","author":"Aquaro","year":"2020","journal-title":"Int J Cardiol Hear Vasc"},{"key":"10.1016\/j.hfc.2024.03.002_bib12","first-page":"1","article-title":"Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics","volume":"19","author":"Williams","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2024.03.002_bib13","first-page":"101167","article-title":"CMR-based right ventricular strain analysis in cardiac amyloidosis and its potential as a supportive diagnostic feature","volume":"44","author":"Eckstein","year":"2023","journal-title":"IJC Hear Vasc"},{"key":"10.1016\/j.hfc.2024.03.002_bib14","doi-asserted-by":"crossref","first-page":"690240","DOI":"10.3389\/fcvm.2021.690240","article-title":"Quantitative assessment of left and right atrial strains using cardiovascular magnetic resonance based tissue tracking","volume":"8","author":"Qu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hfc.2024.03.002_bib15","article-title":"Diffusion tensor cardiovascular magnetic resonance imaging: a clinical perspective","author":"Khalique","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib19","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial edema and prognosis in amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib20","first-page":"A17","article-title":"Myocardial perfusion mapping in cardiac amyloidosis- unearthing the spectrum from infiltration to ischaemia","volume":"105","author":"Kotecha","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2024.03.002_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.amjcard.2015.05.021","article-title":"Characterization of cardiac amyloidosis by atrial late gadolinium enhancement using contrast-enhanced cardiac magnetic resonance imaging and correlation with left atrial conduit and contractile function","volume":"116","author":"Kwong","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/13506129.2015.1020153","article-title":"Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging","volume":"22","author":"Kristen","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.hfc.2024.03.002_bib23","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.03.002_bib24","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jcmg.2016.01.036","article-title":"Prognostic value of late gadolinium enhancement CMR in systemic amyloidosis","volume":"9","author":"Raina","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib25","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","article-title":"Myocardial amyloidosis: the exemplar interstitial disease","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s10554-014-0436-6","article-title":"Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis","volume":"30","author":"Aquaro","year":"2014","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib27","first-page":"20358","article-title":"Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis","volume":"10","author":"Pucci","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hfc.2024.03.002_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12968-020-00690-4","article-title":"Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance","volume":"22","author":"Martini","year":"2020","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hfc.2024.03.002_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib30","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib32","first-page":"E000029","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib33","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the esc working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.03.002_bib34","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: A Cardiac MR Imaging Study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.hfc.2024.03.002_bib35","doi-asserted-by":"crossref","first-page":"E012506","DOI":"10.1161\/CIRCIMAGING.121.012506","article-title":"Cardiac magnetic resonance\u2013derived extracellular volume mapping for the quantification of hepatic and splenic amyloid","volume":"14","author":"Chacko","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hfc.2024.03.002_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.03.002_bib37","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2024.03.002_bib38","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical comparison of documents from scientific societies on cardiac amyloidosis: JACC state-of-the-art review","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00392-020-01799-3","article-title":"Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK)","volume":"110","author":"Yilmaz","year":"2021","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib40","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the american heart association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2024.03.002_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cjca.2019.12.034","article-title":"Canadian cardiovascular society\/canadian heart failure society joint position statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hfc.2024.03.002_bib42","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1253\/circj.CJ-20-0110","article-title":"JCS 2020 Guideline on diagnosis and treatment of cardiac amyloidosis","volume":"84","author":"Kitaoka","year":"2020","journal-title":"Circ J"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713624000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T12:25:59Z","timestamp":1717590359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713624000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1551713624000187"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2024.03.002","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Magnetic Resonance in the Management of Cardiac Amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2024.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}